Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

This week, CATL, a leading domestic lithium battery company, launched its Hong Kong IPO, heating up the lithium battery sector.

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

Market though is overflowing with rivals and fierce price clashes. Read more at straitstimes.com. Read more at ...

China-based Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a regulatory filing made on Thursday.

Demand for the Hong Kong dollar hasn’t been this strong since Ant Group planned the world’s biggest IPO in the city almost ...

Chinese EV battery giant CATL aims to raise US$4 billion in its Hong Kong listing scheduled for May 20, said a statement ...